Search results
Tematy dnia
22 kwi 2022 · Today, WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk of hospital admission, calling it the best therapeutic choice for high-risk patients to date.
22 gru 2021 · Remdesivir improves clinical outcomes in patients hospitalized with moderate-to-severe coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in symptomatic, nonhospitalized patients...
22 paź 2020 · Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40...
Today, FDA approved Veklury (remdesivir), the first drug approved to treat COVID-19, for use in adults and pediatric patients 12 years of age and older and weighing at least 40 kg (about 88...
25 cze 2020 · Remdesivir is the first medicine against COVID-19 to be recommended for authorisation in the EU. Data on remdesivir were assessed in an exceptionally short timeframe through a rolling review procedure, an approach used by EMA during public health emergencies to assess data as they become available.
20 paź 2020 · The antiviral remdesivir shortened recovery time for patients hospitalized with COVID-19, based on results from the completed trial. Researchers are now testing remdesivir in combination with antibodies and other medications.
21 sty 2022 · The F.D.A. expands its approval of remdesivir to patients who are not hospitalized. The treatment must be given via intravenous infusion over three consecutive days, generally at a hospital or...
